Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor

Leukemia Research

Volumn 28, Issue 5, 2004, Pages 525-532

  Higuchi, Takakazu ^a   Kizaki, Masahiro ^b   Omine, Mitsuhiro ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; ATRA resistance; Granulocyte colony stimulating factor; UF 1

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GRANULOCYTE; GROWTH DISORDER; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRETINOIN; TYROSINE;

EID: 1842559726     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.09.014     Document Type: Article

References (44)

1. Degos L., Dombret H., Chomienne C., Daniel M.-T., Micléa J.-M., Chastang C.et al. All-trans-retinoid acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 85:1995;2643-2653.
2. Fenaux P., Chastang C., Chevret S., Sanz M., Dombret H., Archimbaud E.et al. A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood. 94:1999;1192-1200.
3. Asou N., Adachi K., Tamura J., Kanamaru A., Kageyama S., Hiraoka A.et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J. Clin. Oncol. 16:1998;78-85.
4. Douer D. Advances in the treatment of relapsed acute promyelocytic leukemia. Acta Haematol. 107:2002;1-17.
5. Soignet S.L., Frankel S.R., Douer D., Tallman M.S., Kantarjian H., Calleja E.et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 19:2001;3852-3860.
6. Huang S.-Y., Yang C.-H., Chen Y.-C. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy. Leuk. Lymphoma. 38:2000;283-293.
7. Warrell R.P. Jr., He L.-Z., Richon V., Calleja E., Pandolfi P.P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90:1998;1621-1625.
8. Zhou D.-C., Kim S.H., Ding W., Schults C., Warrell R.P. Jr., Gallagher R.E. Frequent mutations in the ligand-binding domain of PML-RARα after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood. 99:2002;1356-1363.
9. Novic S., Camacho L., Gallagher R., Chanel S., Ho R., Tolentino T.et al. Initial clinical evaluation of 'transcription therapy' for cancer: all-trans retinoic acid plus phenylbutyrate (abstr.). Blood. 94(Suppl. 1):1999;61.
10. Kizaki M., Matsushita H., Takayama N., Muto A., Ueno H., Awaya N.et al. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood. 88:1996;1824-1833.
11. Park D.J., Chumakov A.M., Vuong P.T., Chih D.Y., Gombart A.F., Miller W.H. Jr. et al. CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment. J. Clin. Invest. 103:1999;1399-1408.
12. Muindi J., Frankel S.R., Miller W.H. Jr., Jakubowski A., Scheinberg D.A., Young C.W.et al. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood. 79:1992;299-303.
13. Delva L., Cornic M., Balitrand N., Guidez F., Micléa J.-M., Delmer A.et al. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood. 82:1993;2175-2181.
14. Kizaki M., Ueno H., Yamazoe Y., Shimada M., Takayama N., Muto A.et al. Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood. 87:1996;725-733.
15. Muindi J.R.F., Frankel S.R., Huselton C., DeGrazia F., Garland W.A., Young C.W.et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 52:1992;2138-2142.
16. Imaizumi M., Suzuki H., Yoshinari M., Sato A., Saito T., Sugawara A.et al. Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood. 92:1998;374-382.
17. Ding W., Li Y.-P., Nobile L.M., Grills G., Carrera I., Paietta E.et al. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood. 92:1998;1172-1183.
18. Coté S., Zhou D., Bianchini A., Nervi C., Gallagher R.E., Miller W.H. Jr. Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia. Blood. 96:2000;3200-3208.
19. Takayama N., Kizaki M., Hida T., Kinjo K., Ikeda Y. Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia. Exp. Hematol. 29:2001;864-872.
20. Coté S., Rosenauer A., Bianchini A., Seiter K., Vandewiele J., Nervi C.et al. Response to histone deacetylase inhihition of novel PML/RARα mutants detected in retinoic acid-resistant APL cells. Blood. 100:2002;2586-2596.
21. Pébusque M.-J., Lafage M., Lopez M., Mannoni P. Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony-stimulating factor. Blood. 72:1988;257-265.
22. Nakamaki T., Sakashita A., Sano M., Hino K., Suzuki K., Tomoyasu S.et al. Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells in vitro. Jpn. J. Cancer Res. 80:1989;1077-1082.
23. Imaizumi M., Sato A., Koizumi Y., Inoue S., Suzuki H., Suwabe N.et al. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/ macrophage colony-stimulating factors in combination with all-trans retinoic acid. Leukemia. 8:1994;1301-1308.
24. Miyauchi J., Inatomi Y., Ohyashiki K., Asada M., Mizutani S., Toyama K. The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia. Leuk. Res. 21:1997;285-294.
25. Katayama N., Kita K., Kawakami K., Mitani H., Sugawara T., Mizuno S.et al. Granulocyte colony-stimulating factor and its receptor in acute promyelocytic leukemia. Am. J. Hematol. 58:1998;31-35.
26. Santini V., Colombat P., Delwel R., van Gurp R., Touw I., Löwenberg B. Induction of granulocytic maturation in acute myeloid leukemia by G-CSF and retinoic acid. Leuk. Res. 15:1991;341-350.
27. Gianní M., Terao M., Zanotta S., Barbui T., Rambaldi A., Garattini E. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood. 83:1994;1909-1921.
28. Gianní M., Li Calzi M., Terao M., Rambaldi A., Garattini E. Tyrosine kinases but not cAMP-dependent protein kinase mediate the induction of leukocyte alkaline phosphatase by granulocyte-colony-stimulating factor and retinoic acid in acute promyelocytic leukemia cells. Biochem. Biophys. Res. Commun. 208:1995;846-854.
29. Hsu H.-C., Tsai W.-H., Chen P.-G., Hsu M.-L., Ho C.-K., Wang S.-Y. In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur. J. Haematol. 63:1999;11-18.
30. Tkatch L.S., Rubin K.A., Ziegler S.F., Tweardy D.J. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J. Leukoc. Biol. 57:1995;964-971.
31. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H. Jr., Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391:1998;811-814.
32. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M.et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature. 391:1998;815-818.
33. Liu T.-X., Zhang J.-W., Tao J., Zhang R.-B., Zhang Q.-H., Zhao C.-J.et al. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood. 96:2000;1496-1504.
34. Yamanaka R., Kim G.-D., Radomska H.S., Lekstrom-Himes J., Smith L.T., Antonson P.et al. CCAAT/enhancer binding protein ε is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6462-6467.
35. Morosetti R., Park D.J., Chumakov A.M., Grillier I., Shiohara M., Gombart A.F.et al. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic, differentiation. Blood. 90:1997;2591-2600.
36. Chih D.Y., Chumakov A.M., Park D.J., Silla A.G., Koeffler H.P. Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBPε). Blood. 90:1997;2987-2994.
37. Verbeek W., Gombart A.F., Chumakov A.M., Müller C., Friedman A.D., Koeffler H.P. C/EBPε directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood. 93:1999;3327-3337.
38. Tian S.-S., Lamb P., Seidel H.M., Stein R.B., Rosen J. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood. 84:1994;1760-1764.
39. Shimoda K., Feng J., Murakami H., Nagata S., Watling D., Rogers N.C.et al. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood. 90:1997;597-604.
40. Shimozaki K., Nakajima K., Hirano T., Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272:1997;25184-25189.
41. Minami M., Inoue M., Wei S., Takeda K., Matsumoto M., Kishimoto T.et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. U.S.A. 93:1996;3963-3966.
42. Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kikuchi N.et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15:1996;3651-3658.
43. Gianni M., Terao M., Fortino I., LiCalzi M., Viggiano V., Barbui T.et al. Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood. 89:1997;1001-1012.
44. Pelicano L., Li F., Schindler C., Chelbi-Alix M.K. Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanism of action. Oncogene. 15:1997;2349-2359.